Form D · Other Health Care
VERAN MEDICAL TECHNOLOGIES, INC.
St. Louis, MO · CIK 0001312458
Offering snapshot reported Sep 30, 2015 · SEC filing
- Reported sold
- $41.7M Offering amount: $47.7M
- Investors reported
- 29 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 18, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 30, 2015 | Initial | $41,720,060 | No comparison | 29 | SEC filing |
| Oct 30, 2014 | Initial | $2,279,623 | No comparison | 11 | SEC filing |
| Jul 3, 2014 | Amendment | $6,500,113 | $1,658,057vs Mar 24, 2014 | 18 | SEC filing |
| May 9, 2014 | Amendment | $5,000,000 | $157,944vs Mar 24, 2014 | 16 | SEC filing |
| Mar 24, 2014 | Amendment | $4,842,056 | $1,887,546vs Jan 14, 2014 | 16 | SEC filing |
| Jan 14, 2014 | Initial | $2,954,510 | No comparison | 16 | SEC filing |
| Oct 3, 2011 | Amendment | $19,073,691 | $175,000vs Sep 1, 2011 | 29 | SEC filing |
| Sep 1, 2011 | Amendment | $18,898,691 | $8,999,999vs Mar 29, 2011 | 27 | SEC filing |
| Jun 27, 2011 | Initial | $16,898,690 | No comparison | 25 | SEC filing |
| Mar 29, 2011 | Initial | $9,898,692 | No comparison | 11 | SEC filing |
| Oct 13, 2010 | Initial | $484,000 | No comparison | 2 | SEC filing |
| Apr 19, 2010 | Initial | $950,000 | No comparison | 3 | SEC filing |
| Aug 26, 2009 | Initial | $1,400,000 | No comparison | 3 | SEC filing |
| May 19, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 19, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 24, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 23, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-248449
Total offering amount includes conversion of convertible promissory notes into shares of preferred stock.
Source: Form D, filed Sep 30, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Adair | Director |
| Frank Bonsal | Director |
| Richard Davis, Md | Director |
| Jeremy Degenhart | Director |
| Ryan Denney | Executive |
| Jerome R. Edwards | Director, Executive |
| Curt Hartman | Director |
| Troy Holsing | Executive |
| Mark Hunter | Executive |
| Greg Johnon, Ph.D. | Director |
| Greg Johnson | Director |
| Gregory Johnson | Director |
| Greg Johnson, Ph.D | Director |
| Greg Johnson, Ph.D. | Director |
| Tom Lowe | Director |
| Maureen Oehler | Executive |
| Robert Paulson | Director |
| Jason Pesterfield | Director, Executive |
| Robert Powers | Executive |
| Ajit Shah | Director |
| Scott Wrightstone | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1908 Innerbelt Business Center Dr.
St. Louis, MO, 63114
St. Louis, MO, 63114